A combination of two types of therapeutic agents selectively killed breast cancer cells in a clinical trial, offering hope ...

As Roche comes under competitive pressure on its breast cancer business, the Swiss company hopes a new drug will add a ...

Discover the future of Decentralized clinical trials in Boston & Tokyo with thought leaders discussing innovation in pharma and healthcare advancements Hema Dubey AKTHealth email us here Visit us on ...

Sumic IT Solutions Ltd has introduced their innovative AI-based tool, AKT, designed to revolutionize team management.

Grayscale has updated its list of potential investment assets to include 36 new cryptocurrencies, including popular tokens ...

2025 Chevy Silverado EV Finally Starts At A Better Price: $57,095 Avoid These 5 Mistakes After Waking Up in The Morning || ...

Shorebirds Brewing Co., which opened in 2022, announced last week that it is closing. The business offers hard kombuchas in ...

Structural engineer Hanif Kara has been named the winner of this year's Soane Medal for "realising some of the most ...

Triple negative breast cancer (TNBC) remains the most aggressive and deadly type of breast cancer, but new findings from ...

Transforming Clinical Research Speaking at Markets&Markets Discover how Decentralized Clinical Trials & Real-worldEvide ...

Structural engineer Hanif Kara, co-founder of AKT II, has been awarded this year’s Soane Medal Sir John Soane’s Museum ...

Novartis' Piqray/Vijoice (alpelisib) is the only PIK3CA inhibitor to have reached the market for breast cancer, having been ...